Holen Sie sich die Stockscreener-App
0.387
1.78%
-0.007
Handel nachbörslich:
.39
0.003
+0.78%
Schlusskurs vom Vortag:
$0.394
Offen:
$0.381
24-Stunden-Volumen:
67,835
Relative Volume:
0.13
Marktkapitalisierung:
$15.26M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-117.67M
KGV:
-0.1252
EPS:
-3.09
Netto-Cashflow:
$-101.06M
1W Leistung:
-2.15%
1M Leistung:
+4.26%
6M Leistung:
+3.48%
1J Leistung:
-36.61%
1-Tages-Spanne:
$0.3764
$0.3922
1-Wochen-Bereich:
$0.3711
$0.394
52-Wochen-Spanne:
$0.2195
$0.8264
Athira Pharma Inc Stock (ATHA) Company Profile
Firmenname
Athira Pharma Inc
Sektor
Branche
Telefon
(425) 620-8501
Adresse
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL
Vergleichen Sie ATHA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATHA
Athira Pharma Inc
|
0.387 | 15.26M | 0 | -117.67M | -101.06M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Athira Pharma Inc Stock (ATHA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-19 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-09-04 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-09-04 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-09-04 | Herabstufung | Rodman & Renshaw | Buy → Neutral |
| 2024-08-19 | Eingeleitet | Rodman & Renshaw | Buy |
| 2022-10-17 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-06-23 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-06-23 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-23 | Herabstufung | Stifel | Buy → Hold |
| 2022-05-10 | Eingeleitet | BTIG Research | Buy |
| 2022-04-21 | Eingeleitet | Berenberg | Buy |
| 2021-12-15 | Eingeleitet | Goldman | Neutral |
| 2020-10-13 | Eingeleitet | Goldman | Buy |
| 2020-10-13 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-10-13 | Eingeleitet | Jefferies | Buy |
| 2020-10-13 | Eingeleitet | Stifel | Buy |
Alle ansehen
Athira Pharma Inc Aktie (ATHA) Neueste Nachrichten
Visualizing Athira Pharma Inc. stock with heatmapsMarket Weekly Review & Daily Entry Point Alerts - Newser
What Fibonacci levels say about Athira Pharma Inc. reboundTrade Signal Summary & Daily Profit Maximizing Tips - Newser
Is Athira Pharma Inc. forming a breakout patternMarket Trend Report & Weekly Setup with ROI Potential - khodrobank.com
Does Athira Pharma Inc. stock benefit from AI growth2025 Trading Volume Trends & Real-Time Market Sentiment Reports - khodrobank.com
Live market analysis of Athira Pharma Inc.2025 Geopolitical Influence & Accurate Buy Signal Alerts - Newser
Using AI based signals to follow Athira Pharma Inc.Weekly Market Outlook & Free Weekly Watchlist of Top Performers - Newser
Using data filters to optimize entry into Athira Pharma Inc.July 2025 PreEarnings & Long-Term Capital Growth Strategies - Newser
Is Athira Pharma Inc. stock bottoming outEarnings Trend Report & Expert Approved Momentum Ideas - Newser
Real time pattern detection on Athira Pharma Inc. stock2025 Volatility Report & Verified Entry Point Detection - Newser
What MACD signals say about Athira Pharma Inc.Dividend Hike & Intraday High Probability Alerts - Newser
Is Athira Pharma Inc. stock reversal real or fakeJuly 2025 Review & Expert Approved Momentum Ideas - Newser
What machine learning models say about Athira Pharma Inc.Short Setup & Low Drawdown Momentum Ideas - Newser
Using economic indicators to assess Athira Pharma Inc. potentialJuly 2025 Summary & Free Long-Term Investment Growth Plans - Newser
Analyzing net buyer seller activity in Athira Pharma Inc.Gap Up & Breakout Confirmation Trade Signals - Newser
Loss Report: Will Athira Pharma Inc. benefit from AI trendsProduct Launch & Detailed Earnings Play Alerts - khodrobank.com
What’s next for Athira Pharma Inc. stock priceQuarterly Earnings Summary & Intraday High Probability Setup Alerts - Newser
Can volume confirm reversal in Athira Pharma Inc.Weekly Trend Summary & Target Return Focused Picks - Newser
Smart tools for monitoring Athira Pharma Inc.’s price action2025 Breakouts & Breakdowns & Weekly Chart Analysis and Trade Guides - Newser
Price momentum metrics for Athira Pharma Inc. explainedMarket Risk Summary & Daily Profit Focused Stock Screening - Newser
Leading vs lagging indicators on Athira Pharma Inc. performanceWeekly Investment Recap & Technical Pattern Based Signals - Newser
Will Athira Pharma Inc. benefit from AI trendsJuly 2025 Setups & Verified Entry Point Detection - khodrobank.com
Does Athira Pharma Inc. show high probability of rebound2025 Market Overview & Weekly Market Pulse Updates - Newser
Athira Pharma (ATHA) Is Paying a $10M Settlement to Investors — Here’s How to Get Your Share - TradingView
Will Athira Pharma Inc. benefit from macro trendsQuarterly Trade Review & Reliable Breakout Forecasts - Newser
Is it too late to sell Athira Pharma Inc.Weekly Trade Report & Weekly Breakout Opportunity Watchlist - Newser
Is Athira Pharma Inc.’s ROIC above industry averageEarnings Summary Report & Long-Term Growth Portfolio Plans - khodrobank.com
Reversal Confirmed Athira Pharma Inc. Stock Rallies Above MAWeekly Profit Analysis & High Return Trade Opportunity Guides - beatles.ru
Is Athira Pharma Inc. meeting your algorithmic filter criteriaMarket Sentiment Summary & Daily Profit Focused Screening - Newser
Technical Models Suggest Athira Pharma Inc. May Rebound SoonJuly 2025 Trade Ideas & Pattern Based Trade Signal System - beatles.ru
Advanced analytics toolkit walkthrough for Athira Pharma Inc.July 2025 Breakouts & Weekly Watchlist of Top Performers - Newser
Applying Elliott Wave Theory to Athira Pharma Inc.2025 Pullback Review & Scalable Portfolio Growth Methods - Newser
How to monitor Athira Pharma Inc. with trend dashboardsMarket Risk Report & Smart Allocation Stock Tips - Newser
Finanzdaten der Athira Pharma Inc-Aktie (ATHA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Athira Pharma Inc-Aktie (ATHA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER |
Jul 01 '25 |
Sale |
0.29 |
8,526 |
2,502 |
168,901 |
| Litton Mark James | President and CEO |
Jun 30 '25 |
Option Exercise |
0.00 |
108,334 |
0 |
350,925 |
| Litton Mark James | President and CEO |
Jul 01 '25 |
Sale |
0.29 |
25,123 |
7,374 |
325,802 |
| San Martin Javier | CHIEF MEDICAL OFFICER |
Jun 30 '25 |
Option Exercise |
0.00 |
46,666 |
0 |
82,507 |
| San Martin Javier | CHIEF MEDICAL OFFICER |
Jul 01 '25 |
Sale |
0.29 |
10,842 |
3,182 |
71,665 |
| Worthington Mark | General Counsel and CCO |
Jun 30 '25 |
Option Exercise |
0.00 |
36,666 |
0 |
120,401 |
| Worthington Mark | General Counsel and CCO |
Jul 01 '25 |
Sale |
0.29 |
8,526 |
2,502 |
111,875 |
| Renninger Robert | SVP, Finance and Accounting |
Jun 30 '25 |
Option Exercise |
0.00 |
12,359 |
0 |
112,083 |
| Renninger Robert | SVP, Finance and Accounting |
Jul 01 '25 |
Sale |
0.29 |
2,897 |
850 |
109,186 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):